search
Back to results

Tonsil Surgery in Recurrent or Chronic Tonsillitis

Primary Purpose

Tonsillitis Recurrent, Tonsillitis Chronic

Status
Completed
Phase
Not Applicable
Locations
Finland
Study Type
Interventional
Intervention
Tonsillectomy
Tonsillotomy
Sponsored by
Oulu University Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Tonsillitis Recurrent focused on measuring tonsillitis, tonsillectomy, tonsillotomy, tonsil surgery

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

The inclusion criteria are:

  • Recurrent tonsillitis episodes:

    • At least 4 episodes in the previous 12 months or at least 3 episodes in 6 months
    • Episodes are disabling, prevent normal functioning and are severe enough for the patient to seek medical attention
    • Episodes are thought to involve the palatine tonsils based on signs found during the episodes (e.g. edema, erythema, exudative tonsillitis, anterior cervical lymphadenitis)
    • No throat cultures or antigen/molecular tests to show infection with group A streptococcus are needed
  • Chronic tonsillitis:

    • Recurrent or chronic throat pain for at least 6 months
    • At least one symptom or sign that indicate that symptoms originate from the palatal tonsils (disturbing tonsil stones, halitosis, anterior cervical lymphadenitis, tonsillar exudates, abnormal tonsillar crypts)
    • Symptomatic treatment has not been effective

The exclusion criteria are:

  • Age less than 18 years
  • Pregnancy
  • History of peritonsillar abscess
  • Previous illness that make prompt same-day surgery unfeasible
  • No electronic identity verification tools

Sites / Locations

  • Lapland Central Hospital
  • Länsi-Pohja Central Hospital
  • Keski-Pohjanmaa Central Hospital
  • Oulu University Hospital
  • Seinäjoki Central Hospital
  • Turun yliopistollinen keskussairaala
  • Vaasan keskussairaala

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Active Comparator

Active Comparator

No Intervention

Arm Label

Tonsillectomy

Tonsillotomy

Watchful waiting

Arm Description

Patients will undergo tonsillectomy under general anesthesia within three weeks after enrollment.

Patients will undergo tonsillotomy under general anesthesia within three weeks after enrollment.

Patients will be closely monitored for the 5-6 months monitoring period.

Outcomes

Primary Outcome Measures

Tonsillectomy Outcome Inventory -14 (TOI-14) follow-up score
TOI-14 is a disease-specific quality of life questionnaire for throat related symptoms in adults. TOI-14 summary scores vary between 0 and 100 with higher values indicating poorer quality of life. Analysis is described in the Detailed Description section.

Secondary Outcome Measures

36-Item short Form Survey (SF-36, RAND-36) follow-up score
Difference in RAND-36 domains scores between groups. RAND-36 instrument produces eight individual values between 0 and 100 (one for each domain), with higher scores indicating better quality of life
Proportion benefiting
Difference in proportions of patients benefiting clinically significantly from the intervention between the groups (minimum important change in TOI-14 score)
Days with throat pain
Difference in the number of days patients have throat pain (severity scaled 0-10) between the groups
Days with halitosis
Difference in the number of days patients have bad breath (severity scaled 0-10) between the groups
Days with bleeding
Difference in the number of days patients have bleeding from the throat (severity scaled 0-10) between the groups
Days with tonsil stones
Difference in the number of days patients have bothering tonsil stones (severity scaled 0-10) between the groups
Days with absence from work
Difference in the number of days patients are absent from work or school due to throat symptoms between the groups
Days with dexketoprofen
Difference in the number of days patients take deksketoprofen 25 mg pain medication due to throat pain between the groups
Days with acetaminophen
Difference in the number of days patients take acetaminophen 1 g pain medication due to throat pain between the groups
Days with oxycodone/naloxone
Difference in the number of days patients take oxycodone/naloxone 5mg/2.5mg pain medication due to throat pain between the groups
Medical visits
Difference in the number of medical visit for throat symptoms between the groups
Antibiotic courses
Difference in the number of antibiotic courses for throat symptoms between the groups
Adverse effect-postoperative bleeding
Frequency of postoperative bleeding in the surgical groups
Adverse effect - postoperative pain
Frequency of postoperative pain in the surgical groups
Adverse effect - postoperative infection
Frequency of postoperative infections in the surgical groups
Adverse effect - dental injury
Frequency of dental injury in the surgical groups
Adverse effect -anesthetic complication
Frequency of anesthetic complication in the surgical groups
Adverse effect - tightness/globus
Difference in proportions having feeling of tightness/globus in throat between the groups
Adverse effect - voice problems
Difference in proportions having voice problems between the groups
Adverse effect - jaw problems
Difference in proportions having mandibular joint problems between the groups

Full Information

First Posted
November 16, 2020
Last Updated
June 9, 2023
Sponsor
Oulu University Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT04657549
Brief Title
Tonsil Surgery in Recurrent or Chronic Tonsillitis
Official Title
Partial or Total Surgical Removal of Palatal Tonsils to Change Quality of Life for Adults With Chronic or Recurrent Tonsillitis: Randomized Controlled Trial.
Study Type
Interventional

2. Study Status

Record Verification Date
June 2023
Overall Recruitment Status
Completed
Study Start Date
December 8, 2020 (Actual)
Primary Completion Date
June 9, 2023 (Actual)
Study Completion Date
June 9, 2023 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Oulu University Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Tonsil surgery is common in adults with recurrent or chronic tonsillitis. The surgical techniques include either partial or total surgical removal of the palatal tonsils (tonsillotomy, TT, and tonsillectomy, TE, respectively). The aim of this study is to find out, whether tonsil surgery improves the quality of life in these patients and whether the lighter TT is as effective as TE. Our main outcome is the disease-specific Tonsillectomy Outcome Inventory-14 (TOI-14) quality of life questionnaire score at 6 months follow-up.
Detailed Description
Rationale Surgical removal of palatal tonsils is among the most common ear, nose and throat operations in adults in Finland. The vast majority of these operations are done for recurrent and chronic tonsillitis. Internationally accepted guidelines for the treatment of these diseases are lacking and the indications for tonsil surgery are practice-based rather than evidence-based. The choice of the surgical technique further confuses the picture. The traditional surgical technique has been the total removal of tonsils (tonsillectomy, TE). The relatively recent introduction of partial resection of tonsils, namely tonsillotomy (TT), is suggested to have the benefits of less postoperative pain and smaller risk of post-operative hemorrhage as compared to TE. The relative efficacy of these two techniques to alleviate infective tonsillar diseases is still unclear. Objectives The main aim of this study is to obtain reliable evidence on, whether tonsil surgery improves the quality of life in adult patients suffering from recurrent or chronic tonsillitis, and whether the lighter TT would be as effective as TE. We will also compare the scores of a generic quality of life questionnaire as well as several other subjective and objective beneficial and harmful outcomes between the groups. Methods In this pragmatic multi-center randomized controlled trial, adult patients suffering from recurrent or chronic tonsillitis will be randomly allocated to three groups: tonsillotomy group (TT), tonsillectomy group (TE) and control group with watchful waiting (WW) in ratio 2:2:1. The patients in the surgical groups are blinded to the operation type (TT or TE). Our hypothesis is that both surgical treatments are more effective than watchful waiting in enhancing quality of life without significant risks (superiority assumption) and that TT is non-inferior to TE when the surgical groups are compared (non-inferiority assumption). Our principal outcome is disease-specific quality of life questionnaire score (Tonsillectomy Outcome Inventory (TOI)-14) at 6 months follow-up. We have validated this questionnaire in Finnish and explored the interpretation of the scores. Secondary outcomes have been listed in the Outcomes section. Separate random allocation lists for the main research center (Oulu University Hospital) and for the four other centers collectively as well as for recurrent and for chronic tonsillitis will be used. Random permuted blocks is used with block size varying between 5 and 10. Based on our earlier study, the principal outcome, TOI-14 score, will most probably be left-truncated at zero and right-skewed. Therefore, both tobit-analysis and covariate analysis is used with log (1+y) transformation. The primary analysis has two phases. Firstly, the TOI-14 score in the combined surgical group (TT+TE) is compared to that in the WW group. Secondly, the score in the TT group is compared to that in the TE group. Effects will be estimated by adjusted mean differences in the log-transformed scores with 95% confidence intervals. Based on our earlier observational studies on the subject, the following covariates are included in the multivariable adjusted model: gender and baseline TOI-14 score together with stratification factors: enrolling center (Oulu vs. others) and main complaint (recurrent vs. chronic tonsillitis). In case there is missing data on the primary outcome, a multiple imputation method will be used. The analyses will be performed on an intention to treat basis. Per protocol analysis will be performed as sensitivity analysis and results from comparisons on secondary outcomes and subgroup analysis (main complaint) are used to generate hypothesis for future trials.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Tonsillitis Recurrent, Tonsillitis Chronic
Keywords
tonsillitis, tonsillectomy, tonsillotomy, tonsil surgery

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Masking Description
Patients in active arms don't know if they are in tonsillectomy or tonsillotomy group
Allocation
Randomized
Enrollment
147 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Tonsillectomy
Arm Type
Active Comparator
Arm Description
Patients will undergo tonsillectomy under general anesthesia within three weeks after enrollment.
Arm Title
Tonsillotomy
Arm Type
Active Comparator
Arm Description
Patients will undergo tonsillotomy under general anesthesia within three weeks after enrollment.
Arm Title
Watchful waiting
Arm Type
No Intervention
Arm Description
Patients will be closely monitored for the 5-6 months monitoring period.
Intervention Type
Procedure
Intervention Name(s)
Tonsillectomy
Other Intervention Name(s)
Extracapsular tonsillectomy, ECTE
Intervention Description
Tonsillectomy is done by monopolar electrocautery, bipolar scissors or cold instruments. First the mucosa of the anterior palatinal arch is incised and tonsillar capsule identified, then tonsillar tissue is removed along the capsule. Any bleeding is coagulated either with monopolar or bipolar electrocautery.
Intervention Type
Procedure
Intervention Name(s)
Tonsillotomy
Other Intervention Name(s)
Intracapsular tonsillectomy, ICTE. Subtotal/intracapsular/partial tonsillectomy, SIPT.
Intervention Description
Tonsillotomy is done using monopolar electrosurgery, bipolar scissors or coblator device. Most of the tonsillar tissue is removed, exceeding the removal behind the line between anterior and posterior palatinal arch so that only thin layer of tonsil tissue is left over the tonsillar capsule.
Primary Outcome Measure Information:
Title
Tonsillectomy Outcome Inventory -14 (TOI-14) follow-up score
Description
TOI-14 is a disease-specific quality of life questionnaire for throat related symptoms in adults. TOI-14 summary scores vary between 0 and 100 with higher values indicating poorer quality of life. Analysis is described in the Detailed Description section.
Time Frame
At the end of five to six months follow-up
Secondary Outcome Measure Information:
Title
36-Item short Form Survey (SF-36, RAND-36) follow-up score
Description
Difference in RAND-36 domains scores between groups. RAND-36 instrument produces eight individual values between 0 and 100 (one for each domain), with higher scores indicating better quality of life
Time Frame
At the end of five to six months follow-up
Title
Proportion benefiting
Description
Difference in proportions of patients benefiting clinically significantly from the intervention between the groups (minimum important change in TOI-14 score)
Time Frame
At the end of five to six months follow-up
Title
Days with throat pain
Description
Difference in the number of days patients have throat pain (severity scaled 0-10) between the groups
Time Frame
At the end of five to six months follow-up
Title
Days with halitosis
Description
Difference in the number of days patients have bad breath (severity scaled 0-10) between the groups
Time Frame
At the end of five to six months follow-up
Title
Days with bleeding
Description
Difference in the number of days patients have bleeding from the throat (severity scaled 0-10) between the groups
Time Frame
At the end of five to six months follow-up
Title
Days with tonsil stones
Description
Difference in the number of days patients have bothering tonsil stones (severity scaled 0-10) between the groups
Time Frame
At the end of five to six months follow-up
Title
Days with absence from work
Description
Difference in the number of days patients are absent from work or school due to throat symptoms between the groups
Time Frame
At the end of five to six months follow-up
Title
Days with dexketoprofen
Description
Difference in the number of days patients take deksketoprofen 25 mg pain medication due to throat pain between the groups
Time Frame
At the end of five to six months follow-up
Title
Days with acetaminophen
Description
Difference in the number of days patients take acetaminophen 1 g pain medication due to throat pain between the groups
Time Frame
At the end of five to six months follow-up
Title
Days with oxycodone/naloxone
Description
Difference in the number of days patients take oxycodone/naloxone 5mg/2.5mg pain medication due to throat pain between the groups
Time Frame
At the end of five to six months follow-up
Title
Medical visits
Description
Difference in the number of medical visit for throat symptoms between the groups
Time Frame
At the end of five to six months follow-up
Title
Antibiotic courses
Description
Difference in the number of antibiotic courses for throat symptoms between the groups
Time Frame
At the end of five to six months follow-up
Title
Adverse effect-postoperative bleeding
Description
Frequency of postoperative bleeding in the surgical groups
Time Frame
At the end of five to six months follow-up
Title
Adverse effect - postoperative pain
Description
Frequency of postoperative pain in the surgical groups
Time Frame
At the end of five to six months follow-up
Title
Adverse effect - postoperative infection
Description
Frequency of postoperative infections in the surgical groups
Time Frame
At the end of five to six months follow-up
Title
Adverse effect - dental injury
Description
Frequency of dental injury in the surgical groups
Time Frame
At the end of five to six months follow-up
Title
Adverse effect -anesthetic complication
Description
Frequency of anesthetic complication in the surgical groups
Time Frame
At the end of five to six months follow-up
Title
Adverse effect - tightness/globus
Description
Difference in proportions having feeling of tightness/globus in throat between the groups
Time Frame
At the end of five to six months follow-up
Title
Adverse effect - voice problems
Description
Difference in proportions having voice problems between the groups
Time Frame
At the end of five to six months follow-up
Title
Adverse effect - jaw problems
Description
Difference in proportions having mandibular joint problems between the groups
Time Frame
At the end of five to six months follow-up

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
The inclusion criteria are: Recurrent tonsillitis episodes: At least 4 episodes in the previous 12 months or at least 3 episodes in 6 months Episodes are disabling, prevent normal functioning and are severe enough for the patient to seek medical attention Episodes are thought to involve the palatine tonsils based on signs found during the episodes (e.g. edema, erythema, exudative tonsillitis, anterior cervical lymphadenitis) No throat cultures or antigen/molecular tests to show infection with group A streptococcus are needed Chronic tonsillitis: Recurrent or chronic throat pain for at least 6 months At least one symptom or sign that indicate that symptoms originate from the palatal tonsils (disturbing tonsil stones, halitosis, anterior cervical lymphadenitis, tonsillar exudates, abnormal tonsillar crypts) Symptomatic treatment has not been effective The exclusion criteria are: Age less than 18 years Pregnancy History of peritonsillar abscess Previous illness that make prompt same-day surgery unfeasible No electronic identity verification tools
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Olli-Pekka Alho, MD, PhD
Organizational Affiliation
Oulu University Hospital, University of Oulu
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Aleksi EJ Laajala, MD
Organizational Affiliation
Oulu University Hospital, University of Oulu
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Paulus Tokola, MD
Organizational Affiliation
Oulu University Hospital, University of Oulu
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Timo J Autio, MD, PhD
Organizational Affiliation
Oulu University Hospital
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Timo J Koskenkorva, MD, PhD
Organizational Affiliation
University of Oulu
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Pasi Ohtonen, M. Sc.
Organizational Affiliation
Division of Operative Care, Oulu University Hospital, Finland
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Esa Läärä, PhD.
Organizational Affiliation
Oulu University
Official's Role
Study Chair
Facility Information:
Facility Name
Lapland Central Hospital
City
Rovaniemi
State/Province
Lapland
ZIP/Postal Code
FIN-96400
Country
Finland
Facility Name
Länsi-Pohja Central Hospital
City
Kemi
ZIP/Postal Code
FIN-94100
Country
Finland
Facility Name
Keski-Pohjanmaa Central Hospital
City
Kokkola
ZIP/Postal Code
FIN-67200
Country
Finland
Facility Name
Oulu University Hospital
City
Oulu
ZIP/Postal Code
FIN-90029
Country
Finland
Facility Name
Seinäjoki Central Hospital
City
Seinäjoki
ZIP/Postal Code
FIN-60220
Country
Finland
Facility Name
Turun yliopistollinen keskussairaala
City
Turku
Country
Finland
Facility Name
Vaasan keskussairaala
City
Vaasa
Country
Finland

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
Study protocol that includes the Informed Consent Form will be sent to a journal for publication, Statistical analysis Plan will be published later in ClinicalTrials.gov web site. The data generated or analyzed during this study will be available from the corresponding investigator on reasonable request.
IPD Sharing Time Frame
Study protocol will be sent for publication within 12 months from the beginning of recruiting. Data from the study will be available starting six months after publication.
IPD Sharing Access Criteria
The data generated or analyzed during this study will be available from the corresponding investigator on reasonable request.
Citations:
PubMed Identifier
32060601
Citation
Laajala A, Autio TJ, Ohtonen P, Alho OP, Koskenkorva TJ. Interpretation of Tonsillectomy Outcome Inventory-14 scores: a prospective matched cohort study. Eur Arch Otorhinolaryngol. 2020 May;277(5):1499-1505. doi: 10.1007/s00405-020-05832-z. Epub 2020 Feb 14.
Results Reference
background
PubMed Identifier
24863677
Citation
Koskenkorva T, Koivunen P, Laara E, Alho OP. Predictive factors for quality of life after tonsillectomy among adults with recurrent pharyngitis: a prospective cohort study. Clin Otolaryngol. 2014 Aug;39(4):216-23. doi: 10.1111/coa.12263.
Results Reference
background
PubMed Identifier
34526073
Citation
Laajala A, Tokola P, Autio TJ, Koskenkorva T, Tastula M, Ohtonen P, Laara E, Alho OP. Total or partial tonsillar resection (tonsillectomy or tonsillotomy) to change the quality of life for adults with recurrent or chronic tonsillitis: study protocol for a randomised controlled trial. Trials. 2021 Sep 15;22(1):617. doi: 10.1186/s13063-021-05539-4.
Results Reference
background

Learn more about this trial

Tonsil Surgery in Recurrent or Chronic Tonsillitis

We'll reach out to this number within 24 hrs